Martinez C, Khvedelidze I, Fekom M, Deau Fischer B, et al. Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, Bone Marrow Transplant 2025 Apr 15. doi: 10.1038/s41409-025-02568.
PMID: 40234724